50 results
8-K
EX-99.1
CALC
CalciMedica Inc
13 May 24
CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
4:39pm
, Phase 2b trial of Auxora™ in acute pancreatitis (AP); topline data expected in 2Q 2024
KOURAGE, Phase 2 trial in severe acute kidney injury (AKI … to be evaluated in a Phase 2 trial in severe acute kidney injury (AKI) with associated acute
hypoxemic respiratory failure (AHRF), which has been
8-K
EX-99.1
CALC
CalciMedica Inc
28 Mar 24
CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
7:15am
trial in severe acute kidney injury (AKI); KOURAGE initiating in 2Q 2024
CRSPA Phase 1/2 trial of Auxora in asparaginase-induced pancreatic toxicity … presented data from preclinical studies of Auxora in AKI at the 29th International Acute Kidney Injury and Continuous Renal Replacement Therapy Conference
8-K
EX-99.1
CALC
CalciMedica Inc
13 Feb 24
Regulation FD Disclosure
5:30pm
be required by law. 2
Investment Highlights Notes: CRAC: Calcium release-activated calcium; AP: Acute Pancreatitis; AKI: Acute Kidney Injury 3 … ; Auxora Acute Kidney Injury Data expected in 2025 ARDS - Ventilated Data expected 1H24; Auxora Will inform the development plan for ARDS COVID-19 Patients
8-K
f4c7u y9iw
13 Feb 24
Regulation FD Disclosure
5:30pm
8-K/A
EX-4.2
the5ee
24 Jan 24
CalciMedica Announces Private Placement of up to Approximately $55 Million
6:09am
8-K/A
EX-99.1
y5a3o2b6b
24 Jan 24
CalciMedica Announces Private Placement of up to Approximately $55 Million
6:09am
8-K/A
io6i0bqfrdxj k93tr
24 Jan 24
CalciMedica Announces Private Placement of up to Approximately $55 Million
6:09am
8-K
EX-99.1
cjoo5pwai4zx
22 Jan 24
CalciMedica Announces Private Placement of up to Approximately $55 Million
8:42am
8-K
EX-4.2
69xtqp
22 Jan 24
CalciMedica Announces Private Placement of up to Approximately $55 Million
8:42am
8-K
sg9i1q9x7s w8ismyvod
22 Jan 24
CalciMedica Announces Private Placement of up to Approximately $55 Million
8:42am
8-K
EX-99.1
dr4t7f1ybj
9 Nov 23
CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
7:05am
8-K
EX-99.1
s54yxo
2 Nov 23
CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition
9:26am
8-K
EX-99.1
oxx2h h5hddtqch
11 Aug 23
Other Events
4:28pm
8-K
EX-99.1
92iv6m ct
10 Aug 23
CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
5:02pm
8-K
EX-99.1
sf8ija jev3d
15 Jun 23
Regulation FD Disclosure
6:15am